Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis

Abstract

Background Case fatality ratios among children with tuberculosis disease are poorly understood, particularly among HIV-infected cases and those not receiving tuberculosis treatment. Methods We carried out a systematic review of the published literature to identify studies of population-representative samples of pediatric (<15 years old) tuberculosis cases. We used random effects meta-analysis to produce pooled estimates of case fatality ratios. We stratified our analyses by whether or not children received tuberculosis treatment, age (0–4 years, 5–14 years), and HIV status. Findings We identified 31 papers comprising 35 datasets representing 82,436 children with tuberculosis disease, of whom 9,273 died. Among children with tuberculosis from the pretreatment era, the pooled case fatality ratio was 21.9% (95% confidence interval [CI]: 18.1%, 26.4%). The pooled case fatality ratio was significantly higher among children aged 0–4 years (43.6%; 95% CI: 36.8%, 50.6%) than among children aged 5–14 years (14.9%; 95% CI: 11.5%, 19.1%). In recent studies where the majority of children had tuberculosis treatment, the pooled case fatality ratio was 0.9% (95% CI: 0.5%, 1.6%). USA surveillance data suggest a substantially higher case fatality ratio among HIV-infected children receiving TB treatment, compared with HIV-uninfected children, especially without antiretroviral treatment. Interpretation Without adequate treatment, children with tuberculosis disease, especially those under five years of age, are at high risk of death. HIV-infected children have an increased mortality risk, even when receiving tuberculosis treatment. Funding US National Institutes of Health, Janssen Global Public Health

The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis

“…Statistical heterogeneity was high for summary statistics from both TB cohorts and especially HIV cohorts, reflecting diverse study settings and dates, and unreported clinical and methodological heterogeneity. However, measures of heterogeneity were comparable with those from similar studies 86. There were a number of limitations of our meta-analyses of TB cohort data.…”

Global burden of drug-resistant tuberculosis in children: a mathematical modelling study

“…9 Without treatment, tuberculosis disease carries a substantial risk of death in children, but if diagnosed and treated, outcomes are excellent. 10 Anti-tuberculosis drug resistance is frequently divided into drug-susceptible (DS)-tuberculosis and multidrug-resistant (MDR)-tuberculosis. DS-tuberculosis suggests that the organism is susceptible to the two most effective first-line medications (isoniazid and rifampicin), whereas MDR-tuberculosis is defined as disease caused by M. tuberculosis resistant to both of these drugs.…”

The burden of multidrug-resistant tuberculosis in children

“…A systematic review and meta-analysis of outcomes among children treated for MDR-TB estimated that 5.9% (95% CI: 1.3%, 10.5%) of children treated for MDR-TB died 9 . A recent literature review of case fatality ratios in children with TB estimated that 22% (95% CI: 18%, 26%) of children (<15 years) with TB died in the era prior to the development of anti-TB treatment 10 . Thus, assuming that the risk of death without TB treatment does not vary by drug resistance profile, we used a case fatality ratio of 22% for children with MDR-TB who do not receive MDR-TB treatment, although we acknowledge that this may overestimate mortality since some children receive treatment for drug-susceptible TB, potentially exposing them to one or two effective antibiotics.…”